Inwald, EC, Ortmann, O, Koller, M, Zeman, F, Hofstädter, F, Evert, M, Brockhoff, G and Klinkhammer-Schalke, M (2017) Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. Breast Cancer Research and Treatment 163 (1), pp. 119-130.
Full text not available from this repository.
Other URL: http://doi.org/10.1007/s10549-017-4151-6
Abstract
The 70-year threshold determines whether patients are eligible or not for the breast cancer screening program in Germany. It is not known whether this age threshold also influences the choice of adjuvant treatment and ultimate outcome. 3463 patients were analyzed from the clinical cancer registry Regensburg (Germany) with primary, non-metastatic invasive breast cancer diagnosed between 2000 and ...
Export bibliographical data
| Item type: | Article | ||||
|---|---|---|---|---|---|
| Date: | 2017 | ||||
| Institutions: | Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Frauenheilkunde) Medicine > Lehrstuhl für Frauenheilkunde und Geburtshilfe (Schwerpunkt Geburtshilfe) Medicine > Lehrstuhl für Pathologie Medicine > Zentren des Universitätsklinikums Regensburg > Tumorzentrum e.V. | ||||
| Identification Number: |
| ||||
| Keywords: | RANDOMIZED CONTROLLED-TRIAL; POPULATION-BASED COHORT; ELDERLY-PATIENTS; PRIMARY THERAPY; FOLLOW-UP; WOMEN; CHEMOTHERAPY; TRASTUZUMAB; SUBTYPES; MANAGEMENT; Tumor biological subtypes; Breast cancer; Mammography screening; Elderly patients; Cancer registry; Overall survival | ||||
| Dewey Decimal Classification: | 600 Technology > 610 Medical sciences Medicine | ||||
| Status: | Published | ||||
| Refereed: | Yes, this version has been refereed | ||||
| Created at the University of Regensburg: | Yes | ||||
| Item ID: | 39066 |
Altmetric